288
glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet
1994;344:578-81.
22.
Rosina F, Pintus C, Meschievitz C, Rizzetto M. A randomized controlled trial of a
12-month course of recombinant human interferon-alpha in chronic delta (type D)
hepatitis: a multicenter Italian study. Hepatology 1991;13(6):1052–1056
23.
Rizzetto M, Verme G. Delta hepatitis-present status. J Hepatol 1985; 1: 187–193.
24.
Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, Ronchi G,
Colombo M. A 28-year study of the course of hepatitis Delta infection: a risk factor
for cirrhosis and hepatocellular carcinoma. Gastroenterology 2009; 136: 1629-1638
25.
Rizzetto M. Hepatitis D: virology, clinical and epidemiological aspects. Acta
Gastroenterol Belg 2000; 63: 221–4.
26.
Jardi R, Rodriguez F, Buti M, et al. Role of hepatitis B, C, and D viruses in dual and
triple infection: Influence of viral genotypes and hepatitis B precore and basal core
promoter mutations on viral replicative interference. Hepatology 2001; 34:404-10.
27.
Mathurin P, Thibault V, Kadidja K, et al. Replication status and histological features
of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat
2000; 7:15-22.
28.
Raimondo G, Brunetto MR, Pontisso P, et al. Longitudinal evaluation reveals a
complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-
coinfected patients. Hepatology 2006; 43:100-7.
29.
Sheng W, Hung C, Kao J, Chang S, Chen M, Hsieh S, Chen P, Chang S: Impact
of hepatitis D virus infection on the long-term outcomes of patients with hepatitis
B virus and HIV coinfection in the era of highly active antiretroviral therapy: a
matched cohort study. Clin Infect Dis 2007; 44: 988–995.
30.
Castellares C, Barreiro P, Martin-Carbonero L, Labarga P, Vispo ME, Casado R,
Galindo L, Garcia-Gasco P, Garcia-Samaniego J, Soriano V: Liver cirrhosis in HIV-
infected patients: prevalence, aetiology and clinical outcome. J Viral Hep at 2008;
15: 165–172.
